B2BROKER Brings TradingView Integration into B2TRADER to Connect Brokers with Global Markets

B2BROKER Brings TradingView Integration into B2TRADER to Connect Brokers with Global Markets GlobeNewswire January 15, 2026 DUBAI, United Arab Emirates, Jan. 15, 2026 (GLOBE NEWSWIRE) — B2BROKER, a global fintech solutions provider for financial institutions, has announced the integration of TradingView into its flagship multi-asset trading platform B2TRADER. TradingView is a globally renowned trading and […]

Springview Holdings Ltd. Announces Strategic Partnership with Jiangsu GSO New Energy Technology Co., Ltd. to Introduce Solar and Green-Energy Solutions for Residential Housing in Singapore

Springview Holdings Ltd. Announces Strategic Partnership with Jiangsu GSO New Energy Technology Co., Ltd. to Introduce Solar and Green-Energy Solutions for Residential Housing in Singapore GlobeNewswire January 15, 2026 Singapore, Jan. 15, 2026 (GLOBE NEWSWIRE) — Springview Holdings Ltd (Nasdaq: SPHL) (“Springview” or the “Company”) today announced that its wholly owned operating subsidiary in Singapore,

Ace Moving Co. Sees Surge in Professional Packing Requests During Peak Winter Moving Season

Ace Moving Co. Sees Surge in Professional Packing Requests During Peak Winter Moving Season Oakland-based Ace Moving Co. reports 30% rise in packing service bookings, reflecting growing demand for safe, organized East Bay relocations GlobeNewswire January 15, 2026 Ace Moving Co. Logo OAKLAND, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) — Ace Moving Co., a full-service

FairPrice Movers Reports Strong Customer Satisfaction in San Jose Long-Distance Moves

FairPrice Movers Reports Strong Customer Satisfaction in San Jose Long-Distance Moves FairPrice Movers reports high customer satisfaction with a 4.9-star Google rating for its long-distance moving services in San Jose. GlobeNewswire January 15, 2026 FairPrice Movers Logo SAN JOSE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) — FairPrice Movers, a full-service moving company based in San

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference Recently IND-Cleared HER2 × CD3 T-Cell Engager Highlighted by Global Biopharmaceutical Partner GlobeNewswire January 15, 2026 BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) — Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid

Metapack(R) Positioned as a Leader in the SPARK Matrix(TM): Multi-Carrier Parcel Management Solutions (MCPMS), Q4 2025 by QKS Group

Metapack(R) Positioned as a Leader in the SPARK Matrix(TM): Multi-Carrier Parcel Management Solutions (MCPMS), Q4 2025 by QKS Group GlobeNewswire January 15, 2026 Pune, India, Jan. 15, 2026 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading MCPMS vendors. Metapack, a leading delivery platform, has received strong ratings

Talen Energy Continues Portfolio Expansion with Acquisition of Additional High-Quality PJM Natural Gas Assets from Energy Capital Partners

Talen Energy Continues Portfolio Expansion with Acquisition of Additional High-Quality PJM Natural Gas Assets from Energy Capital Partners GlobeNewswire January 15, 2026 HOUSTON, Jan. 15, 2026 (GLOBE NEWSWIRE) — Talen Energy Corporation (“Talen,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, announced it has signed definitive agreements to add approximately 2.6 gigawatts of

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia GlobeNewswire January 15, 2026 NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first patient has been dosed

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa This milestone marks significant progress in the first-in-human evaluation of AAVantgarde's dual-AAV gene therapy designed to address the underlying cause of vision loss in patients with USH1B GlobeNewswire January 15, 2026 LONDON and MILAN, Jan. 15, 2026

Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date

Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date GlobeNewswire January 15, 2026 Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, 2029 CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a

Scroll to Top